Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:00 pm Purchase | 2023-12-29 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 125,449,595 8.560% | 6,675,801 (+5.62%) | Filing History |
| 2024-02-09 11:49 am Sale | 2024-02-09 | 13G | Boston Scientific Corporation BSX | MASSACHUSETTS FINANCIAL SERVICES CO | 57,175,974 3.900% | -25,291,495 (-30.67%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Boston Scientific Corporation BSX | FMR LLC | 139,602,739 9.529% | 34,349,164 (+32.63%) | Filing History |
| 2024-01-25 1:48 pm Sale | 2023-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 127,036,665 8.700% | -10,765,981 (-7.81%) | Filing History |
| 2023-02-14 11:31 am Sale | 2022-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 137,802,646 9.600% | -2,313,619 (-1.65%) | Filing History |
| 2023-02-09 11:12 am Purchase | 2022-12-30 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 118,773,794 8.290% | 7,152,164 (+6.41%) | Filing History |
| 2023-02-09 08:23 am Purchase | 2023-02-09 | 13G | Boston Scientific Corporation BSX | FMR LLC | 105,253,575 7.343% | 5,174,008 (+5.17%) | Filing History |
| 2023-02-08 4:07 pm Sale | 2023-02-08 | 13G | Boston Scientific Corporation BSX | MASSACHUSETTS FINANCIAL SERVICES CO | 82,467,469 5.800% | -4,176,859 (-4.82%) | Filing History |
| 2023-02-06 2:59 pm Sale | 2022-12-30 | 13G | Boston Scientific Corporation BSX | Wellington Management Group LLP | 57,736,340 4.030% | -16,685,169 (-22.42%) | Filing History |
| 2023-01-24 1:56 pm Purchase | 2022-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 140,116,265 9.800% | 12,198,610 (+9.54%) | Filing History |
| 2022-02-10 4:03 pm Purchase | 2021-12-31 | 13G | RenovoRx, Inc. RNXT | BOSTON SCIENTIFIC CORP BSX | 543,971 6.106% | 543,971 (New Position) | Filing History |
| 2022-02-09 3:33 pm Purchase | 2021-12-31 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 111,621,630 7.830% | 840,472 (+0.76%) | Filing History |
| 2022-02-09 09:09 am Purchase | 2022-02-08 | 13G | Boston Scientific Corporation BSX | FMR LLC | 100,079,567 7.017% | 34,667,924 (+53.00%) | Filing History |
| 2022-02-08 5:12 pm Sale | 2021-12-31 | 13G | Boston Scientific Corporation BSX | BlackRock Inc. BLK | 127,917,655 9.000% | -8,044,462 (-5.92%) | Filing History |
| 2022-02-04 09:26 am Sale | 2021-12-31 | 13G | Boston Scientific Corporation BSX | Wellington Management Group LLP | 74,421,509 5.220% | -2,844,132 (-3.68%) | Filing History |
| 2022-02-03 4:01 pm Sale | 2021-12-31 | 13G | Pulmonx Corporation LUNG | BOSTON SCIENTIFIC CORP BSX | 0 0.000% | -5,988,106 (Position Closed) | Filing History |
| 2022-02-02 12:46 pm Purchase | 2022-02-02 | 13G | Boston Scientific Corporation BSX | MASSACHUSETTS FINANCIAL SERVICES CO | 86,644,328 6.100% | 86,644,328 (New Position) | Filing History |
| 2021-02-16 1:24 pm Sale | 2021-02-16 | 13G | Boston Scientific Corporation BSX | Capital World Investors | 7,359,271 0.500% | -100,711,986 (-93.19%) | Filing History |
| 2021-02-12 4:40 pm Purchase | 2020-12-31 | 13G | Pulmonx Corporation LUNG | BOSTON SCIENTIFIC CORP BSX | 5,988,106 16.800% | 5,988,106 (New Position) | Filing History |
| 2021-02-10 10:39 am Purchase | 2020-12-31 | 13G | Boston Scientific Corporation BSX | VANGUARD GROUP INC | 110,781,158 7.740% | 1,764,309 (+1.62%) | Filing History |